APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease

This study aimed to evaluate the impact of APOE4 homozygosity on Alzheimer's disease (AD) by examining its clinical, pathological and biomarker changes to see whether APOE4 homozygotes constitute a distinct, genetically determined form of AD. Data from the National Alzheimer's Coordinating...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Nature medicine Ročník 30; číslo 5; s. 1284
Hlavní autoři:	Fortea, Juan, Pegueroles, Jordi, Alcolea, Daniel, Belbin, Olivia, Dols-Icardo, Oriol, Vaqué-Alcázar, Lídia, Videla, Laura, Gispert, Juan Domingo, Suárez-Calvet, Marc, Johnson, Sterling C, Sperling, Reisa, Bejanin, Alexandre, Lleó, Alberto, Montal, Víctor
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.05.2024
Témata:	Age of Onset Aged Aged, 80 and over Alzheimer Disease - cerebrospinal fluid Alzheimer Disease - diagnostic imaging Alzheimer Disease - genetics Alzheimer Disease - pathology Amyloid - genetics Amyloid - metabolism Amyloid beta-Peptides - cerebrospinal fluid Amyloid beta-Peptides - genetics Amyloid beta-Peptides - metabolism Apolipoprotein E3 - genetics Apolipoprotein E4 - genetics Biomarkers - cerebrospinal fluid Cohort Studies Female Homozygote Humans Male Middle Aged Positron-Emission Tomography tau Proteins - cerebrospinal fluid tau Proteins - genetics
ISSN:	1546-170X, 1546-170X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!